Global Human Micobiome Industry 2016 Deep Market Research Report
- QYR609933
- 153 Pages
- June 2016
- Pharmaceuticals
The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The human micobiome market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed.
The report focuses on global major leading industry players providing information such as company profiles, product research status and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The human micobiome industry development trends and marketing channels are analyzed.
With 195 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
1 Industry Overview of Human Micobiome 1
1.1 Definition of Human Micobiome 1
1.1.1 Definition of Human Micobiome 1
1.2 Classification of Human Micobiome 2
1.2.1 Gastrointestinal Tract Human Micobiome 3
1.2.2 Urogenital Tract Human Micobiome 3
1.3 Applications of Human Micobiome 4
1.3.1 Treatment 5
1.3.2 Diagnosis 5
1.4 Industry Chain Structure of Human Micobiome 6
1.5 Industry Overview and Major Regions Status of Human Micobiome 7
1.5.1 Industry Overview of Human Micobiome 7
1.5.2 Global Major Regions Status of Human Micobiome 8
1.6 Industry Policy Analysis of Human Micobiome 8
1.7 Industry News Analysis of Human Micobiome 9
2 Manufacturing Cost Structure Analysis of Human Micobiome 14
2.1 Raw Material Suppliers and Price Analysis of Human Micobiome 14
2.2 Equipment Suppliers and Price Analysis of Human Micobiome 15
2.3 Labor Cost Analysis of Human Micobiome 18
2.4 Other Costs Analysis of Human Micobiome 21
2.5 Manufacturing Cost Structure Analysis of Human Micobiome 22
2.6 Manufacturing Process Analysis of Human Micobiome 23
3 Technical Data and R&D Status Analysis of Human Micobiome 24
3.1 R&D Date of Global Key Manufacturers 24
3.2 Accumulated Investment of Global Key Human Micobiome Manufacturers in 2011-2015 24
3.3 R&D Status and Technology Source of Global Human Micobiome Major Manufacturers in 2015 25
4 Investment Analysis of Human Micobiome by Regions, Types and Manufacturers 26
4.1 Global Investment of Human Micobiome by Regions 2011-2016 26
4.2 Global and Major Regions Investment and Growth Rate of Human Micobiome 2011-2016 29
4.3 Global Investment of Human Micobiome by Types 2011-2016 30
4.4 Global Investment of Human Micobiome by Manufacturers 2011-2016 33
5 Investment and R&D Investment Analysis of Human Micobiome by Types and Manufacturers 40
5.1 Investment and R&D Investment Analysis of Human Micobiome by Types 2011-2016 40
5.2 Investment and R&D Investment Analysis of Human Micobiome by Manufacturers 2011-2016 42
6 Consumption Value Forecast of Human Micobiome by Regions, Types and Applications 48
6.1 Global Consumption Value Forecast of Human Micobiome by Regions 2018-2023 48
6.2 Global Consumption Value Forecast of Human Micobiome by Types 2018-2023 51
6.3 Global Consumption Value Forecast of Human Micobiome by Applications 2018-2023 55
7 Major Region Consumption forecast 59
7.1 Global Consumption and Growth Rate of Human Micobiome 2018-2023 59
7.2 United States Consumption and Growth Rate of Human Micobiome 2018-2023 60
7.3 Europe Consumption and Growth Rate of Human Micobiome 2018-2023 61
8 Major Manufacturers Analysis of Human Micobiome 62
8.1 Vedanta 62
8.1.1 Company Profile 62
8.1.2 Product Specifications 63
8.1.3 Investment and Investment of R&D 64
8.2 Seres Therapeutics 65
8.2.1 Company Profile 65
8.2.2 Product Specifications 66
8.2.3 Investment and Investment of R&D 67
8.3 Second Genome 69
8.3.1 Company Profile 69
8.3.2 Product Specifications 70
8.3.3 Investment and Investment of R&D 71
8.4 Rebiotix 72
8.4.1 Company Profile 72
8.4.2 Product Specifications 73
8.4.3 Investment and Investment of R&D 74
8.5 ActoGeniX (Interxon) 75
8.5.1 Company Profile 75
8.5.2 Product Specifications 76
8.5.3 Investment and Investment of R&D 77
8.6 Enterome BioScience 78
8.6.1 Company Profile 78
8.6.2 Product Specifications 80
8.6.3 Investment and Investment of R&D 81
8.7 AvidBiotics 82
8.7.1 Company Profile 82
8.7.2 Product Specifications 83
8.7.3 Investment and Investment of R&D 84
8.8 4D Pharma Research Ltd 86
8.8.1 Company Profile 86
8.8.2 Product Specifications 87
8.8.3 Investment and Investment of R&D 87
8.9 Enterologics 89
8.9.1 Company Profile 89
8.9.2 Product Specifications 90
8.9.3 Investment and Investment of R&D 91
8.10 Metabogen 92
8.10.1 Company Profile 92
8.10.2 Product Specifications 93
8.10.3 Investment and Investment of R&D 94
8.11 Metabiomics 95
8.11.1 Company Profile 95
8.11.2 Product Specifications 96
8.11.3 Investment and Investment of R&D 97
8.12 Ritter Pharmaceuticals 99
8.12.1 Company Profile 99
8.12.2 Product Specifications 100
8.12.3 Investment and Investment of R&D 101
8.13 Osel 102
8.13.1 Company Profile 102
8.13.2 Product Specifications 103
8.13.3 Investment and Investment of R&D 104
8.14 Symberix 106
8.14.1 Company Profile 106
8.14.2 Product Specifications 107
8.14.3 Investment and Investment of R&D 108
8.15 Miomics 109
8.15.1 Company Profile 109
8.15.2 Product Specifications 110
8.15.3 Investment and Investment of R&D 111
8.16 Symbiotix Biotherapies 113
8.16.1 Company Profile 113
8.16.2 Product Specifications 114
8.16.3 Investment and Investment of R&D 115
8.17 MicroBiome Therapeutics LLC 116
8.17.1 Company Profile 116
8.17.2 Product Specifications 117
8.17.3 Investment and Investment of R&D 118
9 Marketing Trader or Distributor Analysis of Human Micobiome 120
9.1 Marketing Channels Status of Human Micobiome 120
9.2 Traditional medicine Traders or Distributors with Contact Information of Human Micobiome by Regions 120
10 Industry Chain Analysis of Human Micobiome 122
10.1 Upstream Major Raw Materials Suppliers Analysis of Human Micobiome 122
10.2 Upstream Major Equipment Suppliers Analysis of Human Micobiome 123
10.3 Downstream Major Consumers Analysis of Human Micobiome 124
11 Development Trend of Analysis of Human Micobiome 126
11.1 Investment Forecast of Human Micobiome by Regions 126
11.1.1 Global Investment of Human Micobiome by Regions 2016-2021 126
11.1.2 Global and Major Regions Investment and Growth Rate of Human Micobiome 2016-2021 129
11.2 Investment Forecast of Human Micobiome by Types a 131
12 New Project Investment Feasibility Analysis of Human Micobiome 135
12.1 New Project SWOT Analysis of Human Micobiome 135
13 Conclusion of the Global Human Micobiome 2016 Market Research Report 136
Figure Picture of Human Micobiome 2
Table Classification of Human Micobiome 2
Figure Global Investment Market Share of Human Micobiome by Types in 2015 3
Figure Picture Related to Gastrointestinal Tract Human Micobiome 3
Figure Picture Related to Urogenital Tract Human Micobiome 3
Table Applications of Human Micobiome 4
Figure Global Consumption Value Market Share of Human Micobiome by Applications in 2018 4
Figure Treatment Examples (RP-G28 Product) 5
Figure Industry Chain Structure of Human Micobiome 6
Figure Global Human Micobiome Major Manufacturers Investment Market Share in 2015 7
Figure Global Major Regions Human Micobiome Investment Market Share in 2015 8
Table Industry Policy of Human Micobiome 8
Table Industry News List of Human Micobiome 9
Table Raw Material Suppliers Analysis 14
Figure 2011-2016 Price Analysis (USD/500ml) of Microbial broth 15
Table Equipment Suppliers Analysis 15
Figure Equipment Specification of Biomedical Refrigerators 17
Figure Biomedical Refrigerators Price (USD/Unit) 18
Figure Manufacturing Labor Costs in Select Provinces and Countries in 2014 19
Figure Average Manufacturing Cost Index in 2014 19
Table United States Average Hourly Wages (USD/H) in 2015 20
Figure Germany Labor Costs 2013-2015 20
Figure France Labor Costs 2013-2015 21
Table 2015 Global Electricity Price of Industry (USD/KW·h) by Country 21
Table Manufacturing Cost Structure Analysis of Human Micobiome in 2015 22
Figure Manufacturing Process Analysis of Human Micobiome 23
Table R&D Date of Global Human Micobiome Key Manufacturers 24
Table Accumulated Investment (K USD) of Global Key Human Micobiome Manufacturers in 2011-2015 24
Table R&D Status and Technology Source of Global Human Micobiome Major Manufacturers in 2015 25
Table Global Investment (K USD) of Human Micobiome by Regions 2011-2016 26
Figure Global Investment Market Share of Human Micobiome by Regions in 2011 26
Figure Global Investment Market Share of Human Micobiome by Regions in 2012 27
Figure Global Investment Market Share of Human Micobiome by Regions in 2013 27
Figure Global Investment Market Share of Human Micobiome by Regions in 2014 28
Figure Global Investment Market Share of Human Micobiome by Regions in 2015 28
Figure Global Investment (K USD) and Growth Rate of Human Micobiome 2011-2016 29
Figure United States Investment (K USD) and Growth Rate of Human Micobiome 2011-2016 29
Figure Europe Investment (K USD) and Growth Rate of Human Micobiome 2011-2016 30
Table Global Investment (K USD) of Human Micobiome by Types 2011-2016 30
Figure Global Investment Market Share of Human Micobiome by Types in 2011 31
Figure Global Investment Market Share of Human Micobiome by Types in 2012 31
Figure Global Investment Market Share of Human Micobiome by Types in 2013 32
Figure Global Investment Market Share of Human Micobiome by Types in 2014 32
Figure Global Investment Market Share of Human Micobiome by Types in 2015 33
Table Global and Major Manufacturers Investment (K USD) of Human Micobiome 2011-2016 33
Table Global Investment Market Share of Human Micobiome Major Manufacturers 2011-2016 34
Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2011 35
Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2012 36
Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2013 37
Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2014 38
Figure Global Investment Market Share of Human Micobiome Major Manufacturers in 2015 39
Table Investment (K USD) of Human Micobiome by Types 2011-2016 40
Figure Investment (K USD) of Human Micobiome by Types in 2015 40
Table Investment of R&D (K USD) of Human Micobiome by Types 2011-2016 41
Figure Investment of R&D (K USD) of Human Micobiome by Types in 2015 41
Table R&D (%) of Human Micobiome by Types 2011-2016 41
Figure R&D (%) of Human Micobiome by Types in 2015 42
Table Investment (K USD) of Human Micobiome by Manufacturers 2011-2016 42
Figure Investment (K USD) of Human Micobiome by Manufacturers in 2015 43
Table Investment of R&D (K USD) of Human Micobiome by Manufacturers 2011-2016 44
Figure Investment of R&D (K USD) of Human Micobiome by Manufacturers in 2015 45
Table R&D (%) of Human Micobiome by Manufacturers 2011-2016 46
Figure R&D (%) of Human Micobiome by Manufacturers in 2015 47
Table Global Consumption Value Forecast (M USD) of Human Micobiome by Regions 2018-2023 48
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2018 48
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2019 49
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2020 49
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2021 50
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2022 50
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Regions in 2023 51
Table Global Consumption Value Forecast (M USD) of Human Micobiome by Types 2018-2023 51
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2018 52
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2019 52
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2020 53
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2021 53
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2022 54
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Types in 2023 54
Table Global Consumption Value Forecast (M USD) of Human Micobiome by Applications 2018-2023 55
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2018 55
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2019 56
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2020 56
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2021 57
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2022 57
Figure Global Consumption Value Forecast Market Share of Human Micobiome by Applications in 2023 58
Figure Global Consumption (M USD) and Growth Rate of Human Micobiome 2018-2023 59
Figure United States Consumption (M USD) and Growth Rate of Human Micobiome 2018-2023 60
Figure Europe Consumption (M USD) and Growth Rate of Human Micobiome 2018-2023 61
Table Vedanta Information List 62
Table Brief introduction of Vedanta Product 63
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Vedanta 2011-2016 64
Figure Human Micobiome Investment (K USD) and Growth Rate of Vedanta 2011-2016 64
Figure Human Micobiome Investment (K USD) and Global Market Share of Vedanta 2011-2016 65
Table Seres Therapeutics Information List 65
Table Brief introduction of Seres Therapeutics Product 66
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Seres Therapeutics 2011-2016 67
Figure Human Micobiome Investment (K USD) and Growth Rate of Seres Therapeutics 2011-2016 68
Figure Human Micobiome Investment (K USD) and Global Market Share of Seres Therapeutics 2011-2016 68
Table Second Genome Information List 69
Table Brief introduction of Second Genome Product 70
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Second Genome 2011-2016 71
Figure Human Micobiome Investment (K USD) and Growth Rate of Second Genome 2011-2016 71
Figure Human Micobiome Investment (K USD) and Global Market Share of Second Genome 2011-2016 72
Table Rebiotix Information List 72
Table Brief introduction of Rebiotix Product 73
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Rebiotix 2011-2016 74
Figure Human Micobiome Investment (K USD) and Growth Rate of Rebiotix 2011-2016 74
Figure Human Micobiome Investment (K USD) and Global Market Share of Rebiotix 2011-2016 75
Table ActoGeniX (Interxon) Information List 75
Table Brief introduction of ActoGeniX (Interxon) Product 76
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of ActoGeniX (Interxon) 2011-2016 77
Figure Human Micobiome Investment (K USD) and Growth Rate of ActoGeniX (Interxon) 2011-2016 77
Figure Human Micobiome Investment (K USD) and Global Market Share of ActoGeniX (Interxon) 2011-2016 78
Table Enterome BioScience Information List 78
Table Brief introduction of Enterome BioScience Product 80
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Enterome BioScience 2011-2016 81
Figure Human Micobiome Investment (K USD) and Growth Rate of Enterome BioScience 2011-2016 81
Figure Human Micobiome Investment (K USD) and Global Market Share of Enterome BioScience 2011-2016 82
Table AvidBiotics Information List 82
Table Brief introduction of AvidBiotics Product 83
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of AvidBiotics 2011-2016 84
Figure Human Micobiome Investment (K USD) and Growth Rate of AvidBiotics 2011-2016 85
Figure Human Micobiome Investment (K USD) and Global Market Share of AvidBiotics 2011-2016 85
Table 4D Pharma Research Ltd Information List 86
Table Brief introduction of 4D Pharma Research Ltd Product 87
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of 4D Pharma Research Ltd 2011-2016 87
Figure Human Micobiome Investment (K USD) and Growth Rate of 4D Pharma Research Ltd 2011-2016 88
Figure Human Micobiome Investment (K USD) and Global Market Share of 4D Pharma Research Ltd 2011-2016 88
Table Enterologics Information List 89
Table Brief introduction of Enterologics Product 90
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Enterologics 2011-2016 91
Figure Human Micobiome Investment (K USD) and Growth Rate of Enterologics 2011-2016 91
Figure Human Micobiome Investment (K USD) and Global Market Share of Enterologics 2011-2016 92
Table Metabogen Information List 92
Table Brief introduction of Metabogen Product 93
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Metabogen 2011-2016 94
Figure Human Micobiome Investment (K USD) and Growth Rate of Metabogen 2011-2016 94
Figure Human Micobiome Investment (K USD) and Global Market Share of Metabogen 2011-2016 95
Table Metabiomics Information List 95
Table Brief introduction of Metabiomics Product 96
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Metabiomics 2011-2016 97
Figure Human Micobiome Investment (K USD) and Growth Rate of Metabiomics 2011-2016 98
Figure Human Micobiome Investment (K USD) and Global Market Share of Metabiomics 2011-2016 98
Table Ritter Pharmaceuticals Information List 99
Table Brief introduction of Ritter Pharmaceuticals Product 100
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Ritter Pharmaceuticals 2011-2016 101
Figure Human Micobiome Investment (K USD) and Growth Rate of Ritter Pharmaceuticals 2011-2016 101
Figure Human Micobiome Investment (K USD) and Global Market Share of Ritter Pharmaceuticals 2011-2016 102
Table Osel Information List 102
Table Brief introduction of Osel Product 103
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Osel 2011-2016 104
Figure Human Micobiome Investment (K USD) and Growth Rate of Osel 2011-2016 105
Figure Human Micobiome Investment (K USD) and Global Market Share of Osel 2011-2016 105
Table Symberix Information List 106
Table Brief introduction of Symberix Product 107
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Symberix 2011-2016 108
Figure Human Micobiome Investment (K USD) and Growth Rate of Symberix 2011-2016 108
Figure Human Micobiome Investment (K USD) and Global Market Share of Symberix 2011-2016 109
Table Miomics Information List 109
Table Brief introduction of Miomics Product 110
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Miomics 2011-2016 111
Figure Human Micobiome Investment (K USD) and Growth Rate of Miomics 2011-2016 112
Figure Human Micobiome Investment (K USD) and Global Market Share of Miomics 2011-2016 112
Table Symbiotix Biotherapies Information List 113
Table Brief introduction of Symbiotix Biotherapies Product 114
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of Symbiotix Biotherapies 2011-2016 115
Figure Human Micobiome Investment (K USD) and Growth Rate of Symbiotix Biotherapies 2011-2016 115
Figure Human Micobiome Investment (K USD) and Global Market Share of Symbiotix Biotherapies 2011-2016 116
Table MicroBiome Therapeutics LLC Information List 116
Table Brief introduction of MicroBiome Therapeutics LLC Product 117
Table Human Micobiome Investment (K USD), R&D Investment ((K USD), of MicroBiome Therapeutics LLC 2011-2016 118
Figure Human Micobiome Investment (K USD) and Growth Rate of MicroBiome Therapeutics LLC 2011-2016 119
Figure Human Micobiome Investment (K USD) and Global Market Share of MicroBiome Therapeutics LLC 2011-2016 119
Table Marketing Channels of Human Micobiome 120
Table Traditional medicine Traders or Distributors with Contact Information of Human Micobiome by Regions 120
Table Major Raw Materials Suppliers with Contact Information of Human Micobiome 122
Table Major Equipment Suppliers with Contact Information of Human Micobiome 123
Table Major Consumers with Contact Information of Human Micobiome 124
Table Global Investment (K USD) of Human Micobiome by Regions 2016-2021 126
Figure Global Investment Market Share of Human Micobiome by Regions in 2016 126
Figure Global Investment Market Share of Human Micobiome by Regions in 2017 127
Figure Global Investment Market Share of Human Micobiome by Regions in 2018 127
Figure Global Investment Market Share of Human Micobiome by Regions in 2019 128
Figure Global Investment Market Share of Human Micobiome by Regions in 2020 128
Figure Global Investment Market Share of Human Micobiome by Regions in 2021 129
Figure Global Investment (K USD) and Growth Rate of Human Micobiome 2016-2021 129
Figure United States Investment (K USD) and Growth Rate of Human Micobiome 2016-2021 130
Figure Europe Investment (K USD) and Growth Rate of Human Micobiome 2016-2021 130
Table Global Investment (K USD) of Human Micobiome by Types 2016-2021 131
Figure Global Consumption Value Market Share of Human Micobiome by Types in 2016 131
Figure Global Consumption Value Market Share of Human Micobiome by Types in 2017 132
Figure Global Consumption Value Market Share of Human Micobiome by Types in 2018 132
Figure Global Consumption Value Market Share of Human Micobiome by Types in 2019 133
Figure Global Consumption Value Market Share of Human Micobiome by Types in 2020 133
Figure Global Consumption Value Market Share of Human Micobiome by Types in 2021 134
Table New Project SWOT Analysis of Human Micobiome 135
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
